You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

David P. Schenkein

President, Chief Executive Officer & Director at Agios Pharmaceuticals, Inc.
Relationship Science aggregates deep and verified information on over 6 million influential decision makers and the 2 million organizations with which they are associated. From this data, we create a "business social graph" that highlights who knows whom. Here are David P. Schenkein's strongest connections.

People Most Closely Connected to David P. Schenkein

Click the names below to expand relationship details.
John M. Maraganore
Chief Executive Officer at Alnylam Pharmaceuticals, Inc.
Nick Leschly
President & Chief Executive Officer at bluebird bio, Inc.
Lewis C. Cantley
Founder at Agios Pharmaceuticals, Inc.
Charles L. Sawyers
Chairman, Human Oncology & Pathogenesis Program at Memorial Sloan Kettering Cancer Center
Perry Karsen
Venture Partner at Third Rock Ventures
Robert Tepper
Co-Founder at Third Rock Ventures
Kevin P. Starr
Co-Founder at Third Rock Ventures
Robert Taylor Nelsen
Co-Founder at ARCH Venture Partners
Douglas Cole
Co-Founder at Permeon Biologics, Inc.
Ian Clark
Operating Partner at Clarus Ventures
Alexis Borisy
Partner at Third Rock Ventures
Marc Tessier-Lavigne
President at Stanford University
Mark Levin
Partner at Third Rock Ventures
Tak Mak
Founder at Agios Pharmaceuticals, Inc.
Craig B. Thompson
President & Chief Executive Officer at Memorial Sloan Kettering Cancer Center
Xiaodong Wang
Founder at Beigene (Beijing) Co. Ltd.
Troy Cox
Chief Executive Officer at Foundation Medicine, Inc.
Ronald Levy
Director, Lymphoma Program at Stanford Cancer Center
There are 3,040 more people accessible only with RelSci Professional.